Vivoryon Therapeutics AG's total assets for Q4 2025 were €7.52M, an increase of 17.12% from the previous quarter. NL:VVY total liabilities were €2.79M for the fiscal quarter, a -13.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.